Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.

King, C. H.; Muchiri, E. M.; Ouma, J. H.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.

Published Date:

2000 Nov-Dec

Source:

Emerg Infect Dis. 6(6):585-594.

[PDF-222.10 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

King, C. H. ; Muchiri, E. M. ; Ouma, J. H. ;

Description:

We examined the long-term efficacy of praziquantel against Schistosoma haematobium, the causative agent of urinary schistosomiasis, during a school-based treatment program in the Msambweni area of Coast Province, Kenya, where the disease is highly endemic. Our results, derived from treating 4,031 of 7,641 children from 1984 to 1993, indicate substantial year-to- year variation in drug efficacy. However, the pattern of this variation was not consistent with primary or progressive emergence of praziquantel resistance. Mathematical modeling indicated that, at current treatment rates, praziquantel resistance will likely take 10 or more years to emerge.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	11076716.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Human schistosomiasis

Personal Author:

Colley, Daniel G.; Bustinduy, Amaya L.; Secor, W. Evan; King, Charles H.;

Published Date:

Apr 01 2014

Source:

Lancet. 383(9936):2253-2264.

Description:

Human schistosomiasis--or bilharzia--is a parasitic disease caused by trematode flukes of the genus Schistosoma. By conservative estimates, at least 230 million people worldwide are infected with Schistosoma spp. Adult schistosome worms colonise huma...

File Type:

[PDF - 1.36 MB]
Immunology of human schistosomiasis

Personal Author:

Colley, D. G.; Secor, W. E.;

Published Date:

Aug 2014

Source:

Parasite Immunol. 2014; 36(8):347-357.

Description:

There is a wealth of immunologic studies that have been carried out in experimental and human schistosomiasis that can be classified into three main areas: immunopathogenesis, resistance to reinfection and diagnostics. It is clear that the bulk of, i...

File Type:

[PDF - 1.54 MB]
Something old, something new: is praziquantel enough for schistosomiasis control?

Personal Author:

Secor, W Evan; Montgomery, Susan P;

Published Date:

2015

Source:

Future Med Chem. 7(6):681-684.

File Type:

[PDF - 65.92 KB]
When Should the Emphasis on Schistosomiasis Control Move to Elimination?

Personal Author:

Secor, W. Evan; Colley, Daniel G.;

Published Date:

Aug 15 2018

Source:

Trop Med Infect Dis. 2018; 3(3).

Description:

The stated goal of the World Health Organization's program on schistosomiasis is paraphrased as follows: to control morbidity and eliminate transmission where feasible. Switching from a goal of controlling morbidity to interrupting transmission may w...

File Type:

[PDF - 219.89 KB]
Elimination of Schistosomiasis Transmission in Zanzibar: Baseline Findings before the Onset of a Randomized Intervention Trial

Personal Author:

Knopp, Stefanie; Person, Bobbie; Ame, Shaali M.; Mohammed, Khalfan A.; Ali, Said M.; Khamis, I. Simba; Rabone, Muriel; Allan, Fiona; Gouvras, Anouk; Blair, Lynsey; Fenwick, Alan; Utzinger, Jürg; Rollinson, David;

Published Date:

Oct 17 2013

Source:

PLoS Negl Trop Dis. 2013; 7(10).

Description:

BackgroundGaining and sustaining control of schistosomiasis and, whenever feasible, achieving local elimination are the year 2020 targets set by the World Health Organization. In Zanzibar, various institutions and stakeholders have joined forces to e...

File Type:

[PDF - 989.20 KB]